Posted by Michael Wonder on 19 Feb 2024
EMA publishes agenda for 19-22 February 2024 CHMP meeting
19 February 2024 - The EMA has published a draft agenda for this week's CHMP meeting.
The CHMP is due to issue opinions for the following technologies:
- Apremilast
- Influenza vaccine
- Sparsentan
- Nintedanib esylate
- Ustekinumab
- Tofersen
- Flortaucipir (18 F)
- Tislelizumab
- Danicopan
- Retifanlimab
